Angiosafe
AngioSafe is dedicated to solving complex interventional challenges in coronary and peripheral arterial diseases through a series of patented devices and a highly experienced team. Since 2014, the company has been advancing innovative solutions to enable and improve vascular interventions, with plans for commercial approvals and launches.
Industries
Nr. of Employees
small (1-50)
Patents
Products
Patented catheter-based vascular device series
A series of patented catheter-based devices targeting coronary and peripheral arterial disease; devices are at various stages of preclinical and clinical development.
Patented catheter-based vascular device series
A series of patented catheter-based devices targeting coronary and peripheral arterial disease; devices are at various stages of preclinical and clinical development.
Services
Collaborative clinical programs with advanced centers and principal investigators to conduct clinical evaluation of interventional vascular devices.
Strategic advisory services for regulatory planning, nonclinical study design, and clinical strategy to support device development and submissions.
Collaborative clinical programs with advanced centers and principal investigators to conduct clinical evaluation of interventional vascular devices.
Strategic advisory services for regulatory planning, nonclinical study design, and clinical strategy to support device development and submissions.
Expertise Areas
- Interventional cardiology device development
- Clinical trial management and investigator-led programs
- Regulatory strategy and quality management for medical devices
- Preclinical and nonclinical testing
Key Technologies
- Catheter-based endovascular device platforms
- Endovascular device prototyping and design validation
- Preclinical study methods for vascular devices
- Clinical trial coordination for device evaluation